Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/6/2025

Restrictive Lung Disease Diagnosis and Management

Pattern Recognition and Severity Classification

  • The European Respiratory Society defines the severity of restrictive lung disease based on the FEV1 percentage predicted, with moderate severity impairment representing 60-69% predicted 1
  • A proportional reduction in both FEV1 and FVC with a preserved ratio is the hallmark spirometric pattern suggesting restrictive impairment, and an elevated FEV1/FVC ratio of 89% is well above the lower limit of normal, definitively ruling out obstructive lung disease 2
  • The severity classification is as follows:

Essential Next Steps and Diagnostic Considerations

  • Measuring total lung capacity (TLC) is essential to confirm true restrictive lung disease, as spirometry alone cannot confirm true restriction, with a TLC below the 5th percentile of predicted confirming restriction 2, 3
  • Measuring diffusing capacity for carbon monoxide (DLCO) helps differentiate causes of restriction and is an important predictor of mortality in both general populations and specific disease states 1, 2
  • Consider parenchymal causes, such as interstitial lung diseases, and extrapulmonary causes, such as chest wall disorders and neuromuscular diseases, in the differential diagnosis of restrictive lung disease 1, 2, 3

Critical Pitfalls to Avoid

  • Do not diagnose restrictive lung disease based on spirometry alone, as the FVC reduction could represent poor effort, early obstruction with air trapping, or other non-restrictive causes 2
  • Do not use FEV1/FVC ratio to determine severity, as both values decline together in restriction, and severity classification is based solely on FEV1 % predicted 1

REFERENCES

3

Interpreting Spirometry for Lung Disease Diagnosis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025